ITI Mutual Fund launches ITI Pharma and Healthcare Fund

ITI Mutual Fund has launched the ‘ITI Pharma and Healthcare Fund’. The NFO will close for subscription on November 1.

The fund will be jointly managed by Pradeep Gokhale and Rohan Korde. The minimum application amount is Rs 5,000 and in multiples of Re 1 thereafter.

As the name suggests, the fund will invest in the pharma and healthcare sectors and will be benchmarked against Nifty Healthcare Total Return Index.


“The Covid-19 pandemic has given a new thrust to the Indian pharma sector. ITI Pharma and Healthcare Fund are confident of offering a unique investment experience to its investors by adopting diligent and research-backed investment processes," said George Heber Joseph, Chief Executive Officer and Chief Investment Officer, ITI Mutual Fund.

"The fund house follows the investment philosophy of SQL - Margin of Safety, Quality of the business and Low Leverage and offers a superior investment experience to its investors,” he added.

ITI Mutual Fund started its operations in April 2019 and has launched 13 mainstream mutual fund products since then.

The fund house crossed Rs 2,000 crore AUM as of August 2021 this year.

Out of the total of Rs 2,034 crores as on 31st August 2021, equity AUM accounted for Rs 1,460 crore while hybrid and debt schemes accounted for Rs 230 crore and Rs 344 crore respectively.